(Total Views: 481)
Posted On: 03/25/2019 10:00:41 AM
Post# of 39
$CYCC News Article - Publication Identifies Cyclin E as Key Resistance Pathway to Breast Cancer Treated by CDK4/6 Inhibitors and Thereby Amenable to Treatment by CYC065 CDK2/9 Inhibitor https://marketwirenews.com/news-releases/publ...66434.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
